Role of epigenetic changes in hematological malignancies

被引：39

作者：

Lehmann, U ^{[1
]}

Brakensiek, K ^{[1
]}

Kreipe, H ^{[1
]}

机构：

[1] Hannover Med Sch, Inst Pathol, D-30625 Hannover, Germany

来源：

ANNALS OF HEMATOLOGY | 2004年 / 83卷 / 03期

关键词：

epigenetics; DNA methylation; DNA methyltransferases (DNMT); DNMT inhibitors; leukemia; lymphoma; myelodysplastic syndrome (MDS);

D O I：

10.1007/s00277-003-0798-7

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Inactivation of tumor suppressor genes is an important event contributing to the development of neoplasia. In addition to the classic genetic mechanisms of deletion or inactivating point mutations, growth regulatory genes can be functionally inactivated without alterations of the primary sequence by methylation of cytosine residues in the promoter regions of the genes. After introducing epigenetic phenomena in general and the molecular basis of DNA methylation in more detail, this review will present the broad spectrum of alterations in DNA methylation patterns found in hematopoietic malignancies. In addition, the implications for therapy and prognosis will be discussed.

引用

页码：137 / 152

页数：16

共 187 条

[121] Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia [J].

Mizuno, S ;

Chijiwa, T ;

Okamura, T ;

Akashi, K ;

Fukumaki, Y ;

Niho, Y ;

Sasaki, H .

BLOOD, 2001, 97 (05) :1172-1179

[122] Analyses of the genomic methylation status of the human cyclin A1 promoter by a novel real-time PCR-based methodology [J].

Müller-Tidow, C ;

Bornemann, C ;

Diederichs, S ;

Westermann, A ;

Klümpen, S ;

Zuo, PJ ;

Wang, WB ;

Berdel, WE ;

Serve, H .

FEBS LETTERS, 2001, 490 (1-2) :75-78

[123]

Nakamura M, 2001, CANCER RES, V61, P6335

[124]

Nakatsuka SI, 2003, INT J ONCOL, V22, P561

[125] Hypomethylation status of CpG sites at the promoter region and overexpression of the human MDR1 gene in acute myeloid leukemias [J].

Nakayama, M ;

Wada, M ;

Harada, T ;

Nagayama, J ;

Kusaba, H ;

Ohshima, K ;

Kozuru, M ;

Komatsu, H ;

Ueda, R ;

Kuwano, M .

BLOOD, 1998, 92 (11) :4296-4307

[126]

NELKIN BD, 1991, BLOOD, V77, P2431

[127] Frequent hypermethylation of p16 and p15 genes in multiple myeloma [J].

Ng, MHL ;

Chung, YF ;

Lo, KW ;

Wickham, NWR ;

Lee, JCK ;

Huang, DP .

BLOOD, 1997, 89 (07) :2500-2506

[128] Death associated protein kinase: From regulation of apoptosis to tumor suppressive functions and B cell malignancies [J].

Ng, MHL .

APOPTOSIS, 2002, 7 (03) :261-270

[129]

Ng MHL, 2001, CLIN CANCER RES, V7, P1724

[130] Quantitative measure of c-abl and p15 methylation in chronic myelogenous leukemia:: biological implications [J].

Nguyen, TT ;

Mohrbacher, AF ;

Tsai, YC ;

Groffen, J ;

Heisterkamp, N ;

Nichols, PW ;

Yu, MC ;

Lübbert, M ;

Jones, PA .

BLOOD, 2000, 95 (09) :2990-2992

← 8 9 10 11 12 13 14 15 16 17 →